1. Home
  2. NUKK vs IOBT Comparison

NUKK vs IOBT Comparison

Compare NUKK & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nukkleus Inc.

NUKK

Nukkleus Inc.

HOLD

Current Price

$2.41

Market Cap

67.9M

Sector

Finance

ML Signal

HOLD

Logo IO Biotech Inc.

IOBT

IO Biotech Inc.

HOLD

Current Price

$0.32

Market Cap

57.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUKK
IOBT
Founded
2013
2014
Country
United States
Denmark
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.9M
57.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NUKK
IOBT
Price
$2.41
$0.32
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$2.25
AVG Volume (30 Days)
1.7M
27.2M
Earning Date
02-12-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$0.21
52 Week High
$29.79
$2.79

Technical Indicators

Market Signals
Indicator
NUKK
IOBT
Relative Strength Index (RSI) 28.70 37.51
Support Level $2.10 $0.30
Resistance Level $3.87 $0.58
Average True Range (ATR) 0.41 0.09
MACD -0.06 -0.02
Stochastic Oscillator 13.13 27.08

Price Performance

Historical Comparison
NUKK
IOBT

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: